Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Daplusiran/tomligisiran - GSK

Next Previous
Search
Drug Profile

Daplusiran/tomligisiran - GSK

Alternative Names: ARO-HBV; GSK-5637608; JNJ-3989; JNJ-73763989

Latest Information Update: 18 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Arrowhead Pharmaceuticals
  • Developer Arrowhead Pharmaceuticals; Janssen Research & Development; Janssen Sciences Ireland UC; Johnson & Johnson Innovative Medicine
  • Class Amino sugars; Antivirals; Drug conjugates; Small interfering RNA
  • Mechanism of Action RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Hepatitis B; Hepatitis D

Most Recent Events

  • 05 Mar 2025 Janssen Research & Development completes the phase II REEF-D trial in Hepatitis B and Hepatitis D (Combination therapy) in USA, United Kingdom, Turkey, Taiwan, Sweden, Spain, Russia, Japan, Italy, Germany, France, China, Brazil, Australia, New Zealand (SC) (NCT04535544)
  • 11 Nov 2024 Phase-II clinical trials in Hepatitis B (Treatment-experienced) in USA (SC) (NCT06537414)
  • 05 Aug 2024 GSK plans a phase II B-UNITED trial for Hepatitis B (treatment experienced) (NCT06537414)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top